Literature DB >> 21655469

Correspondence (reply): In reply.

Karl-Stefan Delank.   

Abstract

Mesh：

Year:  2011        PMID： 21655469      PMCID： PMC3109285          DOI： 10.3238/arztebl.2011.0358

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  3 in total

Review 1.  The treatment of spinal metastases.

Authors:  Karl-Stefan Delank; Clemens Wendtner; Hans Theodor Eich; Peer Eysel
Journal:  Dtsch Arztebl Int       Date:  2011-02-04       Impact factor: 5.594

2.  Indications and contraindications for vertebroplasty and kyphoplasty.

Authors:  Marc Röllinghoff; Kourosh Zarghooni; Klaus Schlüter-Brust; Rolf Sobottke; Ulf Schlegel; Peer Eysel; Karl-Stefan Delank
Journal:  Arch Orthop Trauma Surg       Date:  2010-03-11       Impact factor: 3.067

3.  First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial.

Authors:  Gareth J Morgan; Faith E Davies; Walter M Gregory; Kim Cocks; Sue E Bell; Alex J Szubert; Nuria Navarro-Coy; Mark T Drayson; Roger G Owen; Sylvia Feyler; A John Ashcroft; Fiona Ross; Jennifer Byrne; Huw Roddie; Claudius Rudin; Gordon Cook; Graham H Jackson; J Anthony Child
Journal:  Lancet       Date:  2010-12-03       Impact factor: 79.321
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.